375 results
Page 4 of 19
8-K
EX-99.1
badz s0nsmmclk6f6
7 Dec 20
ImmunoGen Presents Updated Findings from Phase 1/2 Study of IMGN632 in Blastic Plasmacytoid Dendritic Cell Neoplasm at ASH Annual Meeting
8:02am
8-K
EX-99.1
8m9z3s tfaw
6 Nov 20
ImmunoGen Reports Recent Progress and Third Quarter 2020 Financial Results
6:53am
8-K
EX-99.1
h2pfk60djxqx1l3y7y
19 Oct 20
ImmunoGen and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize Mirvetuximab Soravtansine in Greater China
8:57am
8-K
EX-10.1
h58fkz
25 Sep 20
Entry into a Material Definitive Agreement
4:38pm
424B5
qmr 0r9t2i7rz8g
25 Sep 20
Prospectus supplement for primary offering
4:23pm
8-K
EX-99.1
kf3cz 4u3cwvla52
31 Jul 20
ImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results
8:41am
DEFA14A
wuhx6bi2k4g93pd88ce
3 Jun 20
Additional proxy soliciting materials
8:36am
8-K
EX-99.1
p4naw0
1 May 20
ImmunoGen Reports Recent Progress and First Quarter 2020 Financial Results
6:35am
DEFA14A
sifh y11zio
28 Apr 20
Additional proxy soliciting materials
11:46am
8-K
EX-99.1
pz7t iioz93z0en
14 Feb 20
ImmunoGen Reports Recent Progress and 2019 Financial Results
6:36am
8-K
EX-1.1
j73pvwuh2u8f9d7r4wpq
23 Jan 20
Entry into a Material Definitive Agreement
4:07pm
424B5
msyx8xg gl3p
23 Jan 20
Prospectus supplement for primary offering
4:05pm
424B5
xxwr qygyuof
22 Jan 20
Prospectus supplement for primary offering
4:07pm